← back to search

Quanming Shi

Stanford University · US
Area of research
Immunology · Cancer Research
Research interest
Research interests include Immune Cell Function and Interaction, Cancer Genomics and Diagnostics, CRISPR and Genetic Engineering, and T-cell and B-cell Immunology.
h-index
25
citations
5,441
works
68
NIH funding
primary concept
Biology
email

Recent publications

Enhancer activation from transposable elements in extrachromosomal DNA
Nature Cell Biology 2025cited by 11position: middledoi
Genetic elements promote retention of extrachromosomal DNA in cancer cells
Nature 2025cited by 8position: middledoi
Bidirectional epigenetic editing reveals hierarchies in gene regulation
Nature Biotechnology 2024cited by 40position: middledoi
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
Cancer Cell 2022cited by 341position: middledoi
Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer
Cancer Cell 2022cited by 327position: middledoi
Divergent clonal differentiation trajectories of T cell exhaustion
Nature Immunology 2022cited by 224position: middledoi
The evolutionary dynamics of extrachromosomal DNA in human cancers
Nature Genetics 2022cited by 191position: middledoi
Engineered cell entry links receptor biology with single-cell genomics
Cell 2022cited by 66position: middledoi
Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis
eLife 2022cited by 44position: middledoi
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
Cell 2021cited by 736position: middledoi
ecDNA hubs drive cooperative intermolecular oncogene expression
Nature 2021cited by 328position: middledoi
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
Cell 2021cited by 216position: middledoi
B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells
Cell 2021cited by 213position: middledoi
A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance
The Journal of Experimental Medicine 2021cited by 56position: middledoi
Principles of ecDNA random inheritance drive rapid genome change and therapy resistance in human cancers
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 16position: middledoi
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217
Journal of Clinical Investigation 2020cited by 122position: middledoi
Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation
eLife 2020cited by 58position: middledoi
Satb1 integrates DNA binding site geometry and torsional stress to differentially target nucleosome-dense regions
Nature Communications 2019cited by 39position: middledoi
Abstract C24: Interplay between ECM stiffness, miR-203 and mammographic density
Cancer Epidemiology Biomarkers & Prevention 2017cited by 0position: middledoi
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
Integrative Biology 2015cited by 1,071position: middledoi
Rapid disorganization of mechanically interacting systems of mammary acini
Proceedings of the National Academy of Sciences 2013cited by 152position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Howard Y. Chang · Amgen (United States)13 papers (2019–2025)Julia A. Belk · Stanford University8 papers (2021–2025)Ansuman T. Satpathy · Stanford University7 papers (2021–2022)Kathryn E. Yost · Howard Hughes Medical Institute6 papers (2020–2022)King L. Hung · Scripps Research Institute5 papers (2021–2025)Jan Liphardt · Stanford University5 papers (2013–2020)Paul S. Mischel · Stanford Health Care4 papers (2021–2025)Valerie M. Weaver · University of California, San Francisco4 papers (2013–2020)Ivory Dean · California Institute for Regenerative Medicine3 papers (2015–2020)Vineet Bafna · University of California San Diego3 papers (2021–2025)Kevin R. Parker · Stanford University3 papers (2021–2024)Katerina Kraft · Amgen (United States)3 papers (2024–2025)Yanyan Qi · Stanford University3 papers (2021–2022)Anton G. Henssen · Johns Hopkins University3 papers (2021–2025)Irene Acerbi · University of California, San Francisco3 papers (2015–2020)Janna K. Mouw · Emory University2 papers (2017–2020)Bingfei Yu · University of Southern California2 papers (2021–2022)Luke Cassereau · Arsenal Biosciences (United States)2 papers (2013–2015)Yuriy Pichugin · Princeton University2 papers (2021–2022)Rajarshi P. Ghosh · Howard Hughes Medical Institute2 papers (2013–2019)